AbbVie has agreed to pay $65 million on an option deal with start-up Gilgamesh Pharma, lining up rights to neuroplastogen compounds that can improve neuroplasticity - the ability of the brain to ...

It’s a conceptual model that identifies items in the protocol and organizes them into a machine-readable structure ... World Health Organization (WHO) registries, and EudraCT registries.” ...

This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the ...